245 related articles for article (PubMed ID: 25144244)
1. Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.
Blount JR; Tsou WL; Ristic G; Burr AA; Ouyang M; Galante H; Scaglione KM; Todi SV
Nat Commun; 2014 Aug; 5():4638. PubMed ID: 25144244
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
Sutton JR; Blount JR; Libohova K; Tsou WL; Joshi GS; Paulson HL; Costa MDC; Scaglione KM; Todi SV
Hum Mol Genet; 2017 Apr; 26(8):1419-1431. PubMed ID: 28158474
[TBL] [Abstract][Full Text] [Related]
3. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
Chen ZS; Huang X; Talbot K; Chan HYE
Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.
Tsou WL; Ouyang M; Hosking RR; Sutton JR; Blount JR; Burr AA; Todi SV
Neurobiol Dis; 2015 Oct; 82():12-21. PubMed ID: 26007638
[TBL] [Abstract][Full Text] [Related]
5. Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3.
Johnson SL; Blount JR; Libohova K; Ranxhi B; Paulson HL; Tsou WL; Todi SV
Neurobiol Dis; 2019 Dec; 132():104535. PubMed ID: 31310802
[TBL] [Abstract][Full Text] [Related]
6. Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.
Blount JR; Johnson SL; Libohova K; Todi SV; Tsou WL
J Neurosci Res; 2020 Oct; 98(10):2096-2108. PubMed ID: 32643791
[TBL] [Abstract][Full Text] [Related]
7. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
Doss-Pepe EW; Stenroos ES; Johnson WG; Madura K
Mol Cell Biol; 2003 Sep; 23(18):6469-83. PubMed ID: 12944474
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
Ristic G; Sutton JR; Libohova K; Todi SV
Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine expansion of ataxin-3 alters its degree of ubiquitination and phosphorylation at specific sites.
Kristensen LV; Oppermann FS; Rauen MJ; Hartmann-Petersen R; Thirstrup K
Neurochem Int; 2017 May; 105():42-50. PubMed ID: 28065793
[TBL] [Abstract][Full Text] [Related]
10. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.
Yang H; Yue HW; He WT; Hong JY; Jiang LL; Hu HY
FASEB J; 2018 Jun; 32(6):2923-2933. PubMed ID: 29401586
[TBL] [Abstract][Full Text] [Related]
11. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
Warrick JM; Morabito LM; Bilen J; Gordesky-Gold B; Faust LZ; Paulson HL; Bonini NM
Mol Cell; 2005 Apr; 18(1):37-48. PubMed ID: 15808507
[TBL] [Abstract][Full Text] [Related]
12. Molecular clearance of ataxin-3 is regulated by a mammalian E4.
Matsumoto M; Yada M; Hatakeyama S; Ishimoto H; Tanimura T; Tsuji S; Kakizuka A; Kitagawa M; Nakayama KI
EMBO J; 2004 Feb; 23(3):659-69. PubMed ID: 14749733
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
Elife; 2020 Sep; 9():. PubMed ID: 32955441
[TBL] [Abstract][Full Text] [Related]
14. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
15. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
16. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
[TBL] [Abstract][Full Text] [Related]
17. Rad23 interaction with the proteasome is regulated by phosphorylation of its ubiquitin-like (UbL) domain.
Liang RY; Chen L; Ko BT; Shen YH; Li YT; Chen BR; Lin KT; Madura K; Chuang SM
J Mol Biol; 2014 Dec; 426(24):4049-4060. PubMed ID: 25311859
[TBL] [Abstract][Full Text] [Related]
18. FipoQ/FBXO33, a Cullin-1-based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein.
Chen ZS; Wong AKY; Cheng TC; Koon AC; Chan HYE
J Neurochem; 2019 Jun; 149(6):781-798. PubMed ID: 30685895
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.
Berke SJ; Chai Y; Marrs GL; Wen H; Paulson HL
J Biol Chem; 2005 Sep; 280(36):32026-34. PubMed ID: 16040601
[TBL] [Abstract][Full Text] [Related]
20. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.
Chakraborty A; Tapryal N; Venkova T; Mitra J; Vasquez V; Sarker AH; Duarte-Silva S; Huai W; Ashizawa T; Ghosh G; Maciel P; Sarkar PS; Hegde ML; Chen X; Hazra TK
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8154-8165. PubMed ID: 32205441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
